Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331507 | SCV001523554 | uncertain significance | Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies | 2020-06-10 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV002272450 | SCV002558137 | uncertain significance | not provided | 2022-07-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002272450 | SCV003263447 | uncertain significance | not provided | 2024-01-15 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 329 of the DHX37 protein (p.Val329Ile). This variant is present in population databases (rs112262509, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with DHX37-related conditions. ClinVar contains an entry for this variant (Variation ID: 1030049). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DHX37 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomic Medicine, |
RCV003989681 | SCV004806410 | likely benign | 46,XY sex reversal 11 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002272450 | SCV005192055 | uncertain significance | not provided | criteria provided, single submitter | not provided |